Santhera Pharmaceuticals Holding AG Stock Berne S.E.
Stocks
SANN
CH1276028821
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.28 CHF | 0.00% |
|
0.00% | - |
| Market Cap | 242M 299M 259M 222M 417M 28.46B 423M 2.83B 1.11B 14.26B 1.12B 1.1B 47.16B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 269M 333M 288M 247M 465M 31.72B 472M 3.16B 1.24B 15.9B 1.25B 1.22B 52.57B | EV / Sales 2026 * |
2.84x | EV / Sales 2027 * | 2.28x |
| Free-Float |
81.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Santhera Pharmaceuticals Holding AG
| 1 day | +71.53% |
| Manager | Title | Age | Since |
|---|---|---|---|
Orlando Oliveira
CEO | Chief Executive Officer | 50 | 2026-07-14 |
Catherine Isted
DFI | Director of Finance/CFO | 51 | 2025-02-23 |
Marc Schrader
COO | Chief Operating Officer | 55 | 2022-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Meier
CHM | Chairman | 64 | 2022-06-29 |
| Director/Board Member | 58 | 2017-04-03 | |
Bradley Meyer
BRD | Director/Board Member | 47 | 2023-06-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 299M | |
| +1.19% | +2.07% | +62.95% | +23.53% | 317B | |
| -0.40% | +0.84% | +33.01% | -12.94% | 72.2B | |
| -1.48% | +24.63% | +63.04% | +132.88% | 11.7B | |
| +0.63% | +0.31% | -3.74% | -4.44% | 8.45B | |
| +3.86% | +12.28% | -10.94% | -10.67% | 4.75B | |
| -0.47% | +21.53% | +3.76% | +49.73% | 4.38B | |
| +1.74% | +11.56% | -26.79% | +10.24% | 4.26B | |
| -1.45% | +2.21% | +15.89% | +47.89% | 2.77B | |
| +0.80% | +1.11% | +1.98% | +1.03% | 2.26B | |
| Average | +7.56% | +8.10% | +15.46% | +26.36% | 47.56B | |
| Weighted average by Cap. | +0.88% | +0.29% | +53.64% | +19.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 94.7M 117M 101M 86.87M 163M 11.16B 166M 1.11B 436M 5.59B 440M 431M 18.49B | 116M 143M 124M 106M 199M 13.61B 203M 1.36B 532M 6.82B 537M 525M 22.56B |
| Net income | - | - |
| Net Debt | 27.7M 34.29M 29.66M 25.41M 47.79M 3.26B 48.55M 325M 128M 1.64B 129M 126M 5.41B | 21.4M 26.49M 22.92M 19.63M 36.92M 2.52B 37.51M 251M 98.55M 1.26B 99.48M 97.31M 4.18B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SANN Stock
- SANN Stock
Select your edition
All financial news and data tailored to specific country editions
